Drug comparisons
Pioglitazone vs Vildagliptin
Compare Pioglitazone vs Vildagliptin for type 2 diabetes treatment. TZD vs DPP-4 inhibitor: efficacy, HF risk, weight effects, and safety profiles.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting second-line oral antidiabetic therapy for type 2 diabetes patients, especially those with insulin resistance or cardiovascular considerations.
Bottom line
Neither drug is universally superior; Pioglitazone provides stronger insulin sensitization at the cost of significant risks, while Vildagliptin offers safer, modest glycemic control.
All medication comparisons